Oncothyreon to present at Rodman & Renshaw Global Healthcare Conference

    SEATTLE, WA, Sept. 3 /CNW/ - Oncothyreon Inc. (Nasdaq:   ONTY) (TSX: ONY)
announced today that Robert Kirkman, M.D., President and Chief Executive
Officer, will present at the Rodman & Renshaw 11th Annual Healthcare
Conference taking place Sept. 9-11, 2009 in New York.
    Dr. Kirkman will present at 2 p.m. Eastern Time on Thursday, Sept. 10. A
live and archived webcast of the presentation will be accessible at
http://www.wsw.com/webcast/rrshq15/onty or by visiting the Oncothyreon website
www.oncothyreon.com under the "News & Events" section.

    About Oncothyreon

    Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.

For further information:

For further information: Investor and Media Relations Contact: Julie
Rathbun, Rathbun Communications, (206) 769-9219, ir@oncothyreon.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890